Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Stuart McCracken

Newcastle AuthorsTitleYearFull text
Evangelia Kounatidou
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
Dr Dominic Jones
et al.
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities2019
Dr Stuart McCracken
Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer2019
Dr Stuart McCracken
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry2019
Dr Urszula McClurg
Svitlana Korolchuk
Dr Stuart McCracken
Dr Rakesh Heer
Laura Wilson
et al.
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein2018
Dr Urszula McClurg
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
et al.
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP122018
Dr Urszula McClurg
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival2016
Dr Urszula McClurg
Victoria Harle
Dr Scott Walker
Dr Kelly Coffey
Dr Luke Gaughan
et al.
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer2015
Dr Stuart McCracken
Dr Rakesh Heer
Penile strangulation by a substantial metal napkin ring: successful removal with medtronic midas rex® legend® stylus® drill system2013
Dr Stuart McCracken
Dr Kanagasabai Sahadevan
Professor Hing Leung
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis2012
Dr Stuart McCracken
ERK5 signalling in prostate cancer promotes an invasive phenotype2011
12